HUM vs PMCB
Humana Inc (HUM) versus PharmaCyte Biotech Inc (PMCB) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
PharmaCyte Biotech Inc (PMCB) is a biotechnology company listed on NASDAQ.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported PMCB revenue for 2025-04-30 was $0. Net income was $30.7M. PMCB currently screens at market cap $8.6M.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. PMCB currently screens at market cap $8.6M.
Not investment advice. Open the HUM and PMCB stock pages for the full models.
Not investment advice.